42 related articles for article (PubMed ID: 21677377)
1. Potentiation of tau aggregation by cdk5 and GSK3β.
Lee S; Hall GF; Shea TB
J Alzheimers Dis; 2011; 26(2):355-64. PubMed ID: 21677377
[TBL] [Abstract][Full Text] [Related]
2. Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine.
Patrick C; Crews L; Desplats P; Dumaop W; Rockenstein E; Achim CL; Everall IP; Masliah E
Am J Pathol; 2011 Apr; 178(4):1646-61. PubMed ID: 21435449
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cyclin-dependent kinase 5 but not of glycogen synthase kinase 3-β prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T-cell leukemia virus type I-infected lymphocytes.
Maldonado H; Ramírez E; Utreras E; Pando ME; Kettlun AM; Chiong M; Kulkarni AB; Collados L; Puente J; Cartier L; Valenzuela MA
J Neurosci Res; 2011 Sep; 89(9):1489-98. PubMed ID: 21671254
[TBL] [Abstract][Full Text] [Related]
4. Mechanical injuries of neurons induce tau mislocalization to dendritic spines and tau-dependent synaptic dysfunction.
Braun NJ; Yao KR; Alford PW; Liao D
Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29069-29079. PubMed ID: 33139536
[TBL] [Abstract][Full Text] [Related]
5. Structural determinants for activation of the Tau kinase CDK5 by the serotonin receptor 5-HT7R.
Ackmann J; Brüge A; Gotina L; Lim S; Jahreis K; Vollbrecht AL; Kim YK; Pae AN; Labus J; Ponimaskin E
Cell Commun Signal; 2024 Apr; 22(1):233. PubMed ID: 38641599
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of Tau Protein by CDK2/cyclin A and GSK3β Recombinant Kinases: Analysis of Phosphorylation Patterns by Nuclear Magnetic Resonance Spectroscopy.
El Hajjar L; Bridot C; Nguyen M; Cantrelle FX; Landrieu I; Smet-Nocca C
Methods Mol Biol; 2024; 2754():271-306. PubMed ID: 38512672
[TBL] [Abstract][Full Text] [Related]
7. Cdk5 and GSK3β inhibit fast endophilin-mediated endocytosis.
Ferreira APA; Casamento A; Carrillo Roas S; Halff EF; Panambalana J; Subramaniam S; Schützenhofer K; Chan Wah Hak L; McGourty K; Thalassinos K; Kittler JT; Martinvalet D; Boucrot E
Nat Commun; 2021 Apr; 12(1):2424. PubMed ID: 33893293
[TBL] [Abstract][Full Text] [Related]
8. Tau aggregation following subcortical hemorrhage.
Jaeger E; Bischof GN; Onur OA; Schlamann M; Drzezga A
Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2515-2516. PubMed ID: 38433149
[No Abstract] [Full Text] [Related]
9. Cell-based Models To Investigate Tau Aggregation.
Lim S; Haque MM; Kim D; Kim DJ; Kim YK
Comput Struct Biotechnol J; 2014 Nov; 12(20-21):7-13. PubMed ID: 25505502
[TBL] [Abstract][Full Text] [Related]
10. Dietary Spray-Dried Porcine Plasma Reduces Neuropathological Alzheimer's Disease Hallmarks in SAMP8 Mice.
Rosell-Cardona C; Griñan-Ferré C; Pérez-Bosque A; Polo J; Pallàs M; Amat C; Moretó M; Miró L
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371878
[TBL] [Abstract][Full Text] [Related]
11. Activity of Selected Group of Monoterpenes in Alzheimer's Disease Symptoms in Experimental Model Studies-A Non-Systematic Review.
Wojtunik-Kulesza K; Rudkowska M; Kasprzak-Drozd K; Oniszczuk A; Borowicz-Reutt K
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298986
[TBL] [Abstract][Full Text] [Related]
12. Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease.
Zhang H; Wei W; Zhao M; Ma L; Jiang X; Pei H; Cao Y; Li H
Int J Biol Sci; 2021; 17(9):2181-2192. PubMed ID: 34239348
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in Alzheimer's Disease: Function and Potential Applications as Diagnostic Biomarkers.
Wei W; Wang ZY; Ma LN; Zhang TT; Cao Y; Li H
Front Mol Neurosci; 2020; 13():160. PubMed ID: 32973449
[TBL] [Abstract][Full Text] [Related]
14. Biochemical Markers in Alzheimer's Disease.
Rabbito A; Dulewicz M; Kulczyńska-Przybik A; Mroczko B
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183332
[TBL] [Abstract][Full Text] [Related]
15. Effects of Thioflavin T and GSK-3 Inhibition on Lifespan and Motility in a
Gamir-Morralla A; Sacristán S; Medina M; Iglesias T
J Alzheimers Dis Rep; 2019 Feb; 3(1):47-57. PubMed ID: 30842997
[TBL] [Abstract][Full Text] [Related]
16. The Role of Cdk5 in Alzheimer's Disease.
Liu SL; Wang C; Jiang T; Tan L; Xing A; Yu JT
Mol Neurobiol; 2016 Sep; 53(7):4328-42. PubMed ID: 26227906
[TBL] [Abstract][Full Text] [Related]
17. Cyclin-Dependent kinase 5 targeting prevents β-Amyloid aggregation involving glycogen synthase kinase 3β and phosphatases.
Castro-Alvarez JF; Uribe-Arias A; Cardona-Gómez GP
J Neurosci Res; 2015 Aug; 93(8):1258-66. PubMed ID: 25711385
[TBL] [Abstract][Full Text] [Related]
18. Discovery of thienoquinolone derivatives as selective and ATP non-competitive CDK5/p25 inhibitors by structure-based virtual screening.
Chatterjee A; Cutler SJ; Doerksen RJ; Khan IA; Williamson JS
Bioorg Med Chem; 2014 Nov; 22(22):6409-21. PubMed ID: 25438765
[TBL] [Abstract][Full Text] [Related]
19. Hyperphosphorylated tau is implicated in acquired epilepsy and neuropsychiatric comorbidities.
Zheng P; Shultz SR; Hovens CM; Velakoulis D; Jones NC; O'Brien TJ
Mol Neurobiol; 2014 Jun; 49(3):1532-9. PubMed ID: 24323428
[TBL] [Abstract][Full Text] [Related]
20. Caspase-mediated truncation of tau potentiates aggregation.
Lee S; Shea TB
Int J Alzheimers Dis; 2012; 2012():731063. PubMed ID: 22988541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
